Search research articles
Contact Us
Filters
Showing results (111-120 of 163) with videos related to
Page
of 17
Sort By:
American Journal of Cancer Research
|
March 9, 2022
Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging
Changxian Li, Hongwei Wang, Ruixiang Chen, et al.
Journal of Cellular and Molecular Medicine
|
July 17, 2021
miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
Hao Wang, Zeng Wang, Yirui Wang, et al.
Aging
|
February 11, 2020
Screening and identification of genes associated with cell proliferation in cholangiocarcinoma
Li Guo, Yaodong Zhang, Zibo Yin, et al.
Journal of Gastroenterology and Hepatology
|
February 3, 2015
PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis
Long Zhang, Wei You, Hanze Zhang, et al.
Stem Cells and Development
|
December 23, 2009
Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats
Yue Yu, Ling Lu, Xiaofeng Qian, et al.
International Journal of Biological Sciences
|
July 22, 2022
Erratum: MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
Renjie Yang, Dong Wang, Shen Han, et al.
Hepatology (Baltimore, Md.)
|
March 25, 2018
PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1
Zhiqiang Chen, Wen Gao, Liyong Pu, et al.
International Journal of Biological Sciences
|
January 3, 2022
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
Renjie Yang, Dong Wang, Shen Han, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 11, 2023
Exosome-derived miR-182-5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK/SEMA5a/PI3K pathway
Jifei Wang, Wangjie Jiang, Shuochen Liu, et al.
Journal of Gastroenterology and Hepatology
|
August 30, 2014
Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection
Changjun Huang, Yuan Tian, Rui Peng, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 163) with videos related to
Sort By:
Page
of 17
American Journal of Cancer Research
|
March 9, 2022
Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging
Changxian Li, Hongwei Wang, Ruixiang Chen, et al.
Journal of Cellular and Molecular Medicine
|
July 17, 2021
miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
Hao Wang, Zeng Wang, Yirui Wang, et al.
Aging
|
February 11, 2020
Screening and identification of genes associated with cell proliferation in cholangiocarcinoma
Li Guo, Yaodong Zhang, Zibo Yin, et al.
Journal of Gastroenterology and Hepatology
|
February 3, 2015
PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis
Long Zhang, Wei You, Hanze Zhang, et al.
Stem Cells and Development
|
December 23, 2009
Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats
Yue Yu, Ling Lu, Xiaofeng Qian, et al.
International Journal of Biological Sciences
|
July 22, 2022
Erratum: MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
Renjie Yang, Dong Wang, Shen Han, et al.
Hepatology (Baltimore, Md.)
|
March 25, 2018
PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1
Zhiqiang Chen, Wen Gao, Liyong Pu, et al.
International Journal of Biological Sciences
|
January 3, 2022
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
Renjie Yang, Dong Wang, Shen Han, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 11, 2023
Exosome-derived miR-182-5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK/SEMA5a/PI3K pathway
Jifei Wang, Wangjie Jiang, Shuochen Liu, et al.
Journal of Gastroenterology and Hepatology
|
August 30, 2014
Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection
Changjun Huang, Yuan Tian, Rui Peng, et al.
Page
of 17